Goldman Sachs’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,596
Closed -$71.7K 5110
2022
Q4
$71.7K Sell
4,596
-1,524
-25% -$23.8K ﹤0.01% 4736
2022
Q3
$120K Sell
6,120
-277
-4% -$5.43K ﹤0.01% 4873
2022
Q2
$161K Sell
6,397
-3,917
-38% -$98.6K ﹤0.01% 4966
2022
Q1
$255K Buy
10,314
+5,701
+124% +$141K ﹤0.01% 4964
2021
Q4
$129K Sell
4,613
-6,334
-58% -$177K ﹤0.01% 5150
2021
Q3
$457K Sell
10,947
-4,863
-31% -$203K ﹤0.01% 4433
2021
Q2
$736K Buy
15,810
+2,512
+19% +$117K ﹤0.01% 4213
2021
Q1
$734K Buy
13,298
+3,321
+33% +$183K ﹤0.01% 4117
2020
Q4
$725K Buy
9,977
+5,394
+118% +$392K ﹤0.01% 3637
2020
Q3
$904K Sell
4,583
-2,884
-39% -$569K ﹤0.01% 3371
2020
Q2
$2.09M Sell
7,467
-3,239
-30% -$907K ﹤0.01% 2815
2020
Q1
$1.91M Buy
10,706
+6,228
+139% +$1.11M ﹤0.01% 2790
2019
Q4
$1.1M Sell
4,478
-1,199
-21% -$295K ﹤0.01% 3275
2019
Q3
$670K Buy
5,677
+2,796
+97% +$330K ﹤0.01% 3455
2019
Q2
$466K Buy
2,881
+855
+42% +$138K ﹤0.01% 3555
2019
Q1
$479K Buy
2,026
+268
+15% +$63.4K ﹤0.01% 3573
2018
Q4
$477K Sell
1,758
-1
-0.1% -$271 ﹤0.01% 3425
2018
Q3
$784K Sell
1,759
-4,903
-74% -$2.19M ﹤0.01% 3284
2018
Q2
$3.14M Buy
6,662
+6,202
+1,348% +$2.92M ﹤0.01% 2645
2018
Q1
$271K Sell
460
-177
-28% -$104K ﹤0.01% 3732
2017
Q4
$346K Sell
637
-327
-34% -$178K ﹤0.01% 3603
2017
Q3
$404K Sell
964
-2,704
-74% -$1.13M ﹤0.01% 3607
2017
Q2
$909K Sell
3,668
-1,464
-29% -$363K ﹤0.01% 3201
2017
Q1
$1.57M Buy
+5,132
New +$1.57M ﹤0.01% 2880
2016
Q4
Sell
-1,908
Closed -$165K 4445
2016
Q3
$165K Sell
1,908
-127
-6% -$11K ﹤0.01% 4009
2016
Q2
$136K Buy
+2,035
New +$136K ﹤0.01% 4017
2015
Q4
Sell
-1,042
Closed -$120K 4460
2015
Q3
$120K Buy
1,042
+46
+5% +$5.3K ﹤0.01% 4097
2015
Q2
$230K Sell
996
-499
-33% -$115K ﹤0.01% 3915
2015
Q1
$238K Buy
1,495
+609
+69% +$97K ﹤0.01% 3780
2014
Q4
$84K Sell
886
-301
-25% -$28.5K ﹤0.01% 4283
2014
Q3
$117K Sell
1,187
-66
-5% -$6.51K ﹤0.01% 4184
2014
Q2
$98K Sell
1,253
-511
-29% -$40K ﹤0.01% 4188
2014
Q1
$135K Buy
+1,764
New +$135K ﹤0.01% 4071